- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06567184
Evaluation of the Strong Hearts Urban Program
Pilot Evaluation of the Strong Hearts Program in an Urban Setting
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cultural adaptation of effective health behavior interventions holds the potential to improve health behaviors and ultimately health outcomes among underserved populations. The Strong Hearts (SH) Urban Intervention will adapt the existing SH curriculum for delivery in urban Dallas communities to improve weight status and Life's Essential 8 score for ideal cardiovascular health. Despite declines in heart disease mortality in the United States since 2000, it remains the leading cause of mortality in both men and women-accounting for about one-third of all deaths in the U.S. Costs related to cardiovascular disease (CVD) place a substantial financial burden on the health care system, accounting for an estimated $320 billion in 2016. Although most obesity or CVD prevention programs target only the individual level, the US Centers for Disease Control and Prevention recognizes that health is affected by factors at multiple levels: individual (e.g., behaviors, knowledge, attitudes, skills, psychological factors), social (e.g., influences from one's social network on health-related behaviors), and environmental (e.g., safe places to walk, food choices at workplaces, availability of affordable fruits and vegetables), and recommends integrating approaches to make changes beyond the individual level to support long-term, sustainable behavior change. Providing individuals with the motivation, skills, and opportunity to change behaviors may be less effective if their social or community environment makes it difficult to adopt or maintain these behaviors
SH is a multilevel, multicomponent community-based program, in which an experiential learning focus is combined with social and environmental components, including civic engagement activities related to local resource awareness and enhancement. There is limited knowledge about how programs and services can move beyond commonly used individual-level approaches, which have limitations in terms of cost, impact, reach, and sustainability, to effectively reduce CVD health disparities using an integrated, multi-level, community-engaged approach. This pilot study will provide needed data on the feasibility and preliminary effectiveness of such approaches in urban and underserved communities.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75212
- West Dallas Multipurpose Center
-
Dallas, Texas, United States, 75252
- Texas A&M AgriLife Research and Extension Center at Dallas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women aged 18 or older
- Overweight or obese (BMI≥25)
- Less than 150 minutes of moderate physical activity per week
- Black/African American race and/or Hispanic/Latinx ethnicity
Exclusion Criteria:
- Pregnancy, or intent to become pregnant during the study duration
- Unable to read and communicate in English
- Planning to participate in another health behavior change program in the next three months
- Unable/unwilling to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Strong Hearts Urban
A 12-week multi-level intervention targeting behavior modification, nutrition education, strength training, aerobic exercise, and stress reduction activities
|
A 12-week multi-level intervention targeting behavior modification, nutrition education, strength training, aerobic exercise, and stress reduction activities
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Weight
Time Frame: 12 weeks
|
Change in body weight
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fruit and Vegetable Consumption
Time Frame: 12 weeks
|
Dermal Carotenoid Score.
As measured by Veggie Meter using a participant's index finger, the dermal carotenoid score (0-800) reflects a concentration biomarker of fruit and vegetable intake, where a higher score is correlated with higher intake.
|
12 weeks
|
|
Self-reported healthy eating behaviors
Time Frame: 12 weeks
|
Healthy Eating Index (HEI) as measured by Dietary Health Questionnaire (DHQ-III).
The DHQ-III is a self-administered, web-based food frequency questionnaire scored 0 to 100, where higher scores indicate closer adherence to the Dietary Guidelines for Americans.
|
12 weeks
|
|
Physical activity - Active Minutes
Time Frame: 12 weeks
|
Objectively measured physical activity by Fitbit activity tracker, counted as Active Minutes
|
12 weeks
|
|
Physical activity - Steps
Time Frame: 12 weeks
|
Objectively measured physical activity by Fitbit activity tracker, counted as steps
|
12 weeks
|
|
Participant Acceptability
Time Frame: 12 weeks
|
Participant feedback from follow-up questionnaires measures acceptability on a 5-point Likert scale, where higher score indicates higher satisfaction
|
12 weeks
|
|
Intervention Engagement
Time Frame: 12 weeks
|
Engagement is assessed by attendance at study activities including intervention classes and data collection appointments
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chad D Rethorst, Ph.D., Texas A&M AgriLife Research
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB2022-0801D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Strong Hearts Urban
-
Cornell UniversityTufts University; Montana State University; Bassett HealthcareCompletedObesity | Cardiovascular Disease | Overweight | Sedentary Lifestyle | Heart DiseaseUnited States
-
Duke UniversityFood and Drug Administration (FDA)TerminatedCongenital Heart DiseaseUnited States
-
University of Nebraska LincolnNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Houston and other collaboratorsCompleted
-
University of ManitobaUnity Health Toronto; University of Toronto; Ontario Agency for Health Protection...UnknownCardiovascular Diseases | Diabetes Mellitus | Cardiovascular Risk FactorCanada
-
Judith Garcia-AymerichHospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Hospital del Mar; Instituto de Salud Carlos III and other collaboratorsCompleted
-
Boston UniversityThe University of Texas Health Science Center at San Antonio; RANDUnknownDeploymentUnited States
-
University of WashingtonVA Puget Sound Health Care System; Recreational Equipment, Inc. (REI)Completed
-
University of OregonCompletedSchool ReadinessUnited States
-
Hospital Clinic of BarcelonaRecruiting
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHypertension | Diabetes | Chronic Kidney Diseases | High Blood PressureUnited States